Fondevila, F.; Méndez-Blanco, C.; Fernández-Palanca, P.; Payo-Serafín, T.; van Pelt, J.; Verslype, C.; González-Gallego, J.; Mauriz, J.L.
Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib. Int. J. Mol. Sci. 2021, 22, 11770.
https://doi.org/10.3390/ijms222111770
AMA Style
Fondevila F, Méndez-Blanco C, Fernández-Palanca P, Payo-Serafín T, van Pelt J, Verslype C, González-Gallego J, Mauriz JL.
Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib. International Journal of Molecular Sciences. 2021; 22(21):11770.
https://doi.org/10.3390/ijms222111770
Chicago/Turabian Style
Fondevila, Flavia, Carolina Méndez-Blanco, Paula Fernández-Palanca, Tania Payo-Serafín, Jos van Pelt, Chris Verslype, Javier González-Gallego, and José L. Mauriz.
2021. "Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib" International Journal of Molecular Sciences 22, no. 21: 11770.
https://doi.org/10.3390/ijms222111770
APA Style
Fondevila, F., Méndez-Blanco, C., Fernández-Palanca, P., Payo-Serafín, T., van Pelt, J., Verslype, C., González-Gallego, J., & Mauriz, J. L.
(2021). Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib. International Journal of Molecular Sciences, 22(21), 11770.
https://doi.org/10.3390/ijms222111770